← All trials
NCT07123870
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 23, 2025
- Primary completion
- Oct 29, 2025
- Completion date
- Nov 15, 2025
- First posted
- Aug 14, 2025
- Last posted
- Aug 14, 2025
- Enrollment
- 210
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kocaeli City HospitalLead sponsor
- Kocaeli City HospitalSponsor investigator
- Kocaeli City HospitalOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.